KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Other Operating Expenses (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Other Operating Expenses for 16 consecutive years, with $6.8 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Operating Expenses rose 4.76% year-over-year to $6.8 billion, compared with a TTM value of $25.4 billion through Dec 2024, down 1.36%, and an annual FY2025 reading of $26.7 billion, up 4.4% over the prior year.
  • Other Operating Expenses was $6.8 billion for Q4 2024 at Thermo Fisher Scientific, up from $6.3 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $6.8 billion in Q4 2022 and bottomed at $3.5 billion in Q1 2020.
  • Average Other Operating Expenses over 5 years is $5.6 billion, with a median of $6.2 billion recorded in 2023.
  • The sharpest move saw Other Operating Expenses surged 36.25% in 2022, then fell 6.56% in 2024.
  • Year by year, Other Operating Expenses stood at $5.0 billion in 2020, then grew by 9.09% to $5.4 billion in 2021, then grew by 25.62% to $6.8 billion in 2022, then decreased by 5.13% to $6.5 billion in 2023, then increased by 4.76% to $6.8 billion in 2024.
  • Business Quant data shows Other Operating Expenses for TMO at $6.8 billion in Q4 2024, $6.3 billion in Q3 2024, and $6.2 billion in Q2 2024.